Skip to main content
. 2015 Jun 24;35(25):9315–9328. doi: 10.1523/JNEUROSCI.4808-14.2015

Table 6.

Clinical information for control, AD, and FTLD-TDP subjects

Pathological diagnosis Age at death Gender PMI Other findings
Control
    1 86 F 7.8
    2 76 M 8.2
AD
    1 63 M 6.0
    2 62 M 9.9
    3 72 M 7.9
FTLD-TDP-A
    1 64 M 2.3 AGD
    2 72 M 23.8
    3 78 F 9.0

The pathological diagnosis, age at death, gender, post-mortem interval (PMI), and secondary pathological findings for all subjects in Figure 8 are listed. All subjects were negative for Pgrn mutations. AGD, Argyrophilic grain disease.